Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
44.77
-0.22 (-0.49%)
At close: Jul 10, 2026, 4:00 PM EDT
45.00
+0.23 (0.51%)
After-hours: Jul 10, 2026, 7:59 PM EDT
Boston Scientific (BSX) Revenue by Segment
History
| Date | Cardiology | Endoscopy | Urology | Neuromodulation | Peripheral Interventions | Specialty Pharma |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | 12.27B | 2.98B | 2.72B | 1.25B | 1.40B | - |
| Dec 31, 2025 | 11.19B | 2.92B | 2.71B | 1.20B | 2.06B | - |
| Sep 30, 2025 | 10.01B | 2.85B | 2.62B | 1.17B | 2.70B | - |
| Jun 30, 2025 | 9.50B | 2.78B | 2.47B | 1.14B | 2.60B | - |
| Mar 31, 2025 | 8.90B | 2.72B | 2.32B | 1.12B | 2.49B | - |
| Dec 31, 2024 | 8.35B | 2.69B | 2.20B | 1.11B | 2.41B | - |
| Sep 30, 2024 | 7.80B | 2.64B | 2.10B | 1.08B | 2.30B | - |
| Jun 30, 2024 | 7.32B | 2.59B | 2.05B | 1.04B | 2.23B | - |
| Mar 31, 2024 | 6.97B | 2.55B | 2.01B | 998.00M | 2.18B | - |
| Dec 31, 2023 | 6.71B | 2.48B | 1.96B | 976.00M | 2.11B | - |
| Sep 30, 2023 | 6.49B | 2.41B | 1.91B | 956.00M | 2.05B | - |
| Jun 30, 2023 | 6.32B | 2.34B | 1.86B | 948.00M | 1.99B | - |
| Mar 31, 2023 | 6.13B | 2.27B | 1.83B | 943.00M | 1.94B | - |
| Dec 31, 2022 | 5.93B | 2.22B | 1.77B | 918.00M | 1.90B | - |
| Sep 30, 2022 | 5.83B | 2.21B | 1.74B | 913.00M | 1.88B | - |
| Jun 30, 2022 | 5.69B | 2.18B | 1.69B | 913.00M | 1.86B | - |
| Mar 31, 2022 | 5.58B | 2.17B | 1.64B | 921.00M | 1.85B | - |
| Dec 31, 2021 | 5.42B | 2.14B | 1.58B | 910.00M | 1.82B | 13.00M |
| Sep 30, 2021 | 5.12B | 2.10B | 1.52B | 898.00M | 1.79B | 49.00M |
| Jun 30, 2021 | 4.91B | 2.04B | 1.48B | 893.00M | 1.75B | 123.00M |